Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UPF1 RNA helicase and ATPase (UPF1) is a highly conserved, multifunctional protein that serves as the master regulator of the nonsense-mediated mRNA decay (NMD) pathway (UniProt P78347). It functions as an ATP-dependent RNA helicase that translocates along RNA to displace proteins and remodel ribonucleoprotein complexes, a process essential for the surveillance and degradation of transcripts containing premature termination codons (PubMed: 28223409). Beyond its primary role in NMD, UPF1 is involved in telomere maintenance, DNA replication stress responses, and the regulation of various RNA decay pathways (NCBI Gene: 5976). In the context of human disease, UPF1 is a target of interest in oncology, where NMD inhibition can enhance the expression of tumor-specific neoantigens, potentially sensitizing tumors to immunotherapy (PubMed: 31533975). Additionally, UPF1 modulation is explored in genetic disorders caused by nonsense mutations, where suppressing NMD may restore the expression of truncated but functional proteins (PubMed: 24532341). In neurodegenerative conditions like Amyotrophic Lateral Sclerosis (ALS), UPF1 has shown neuroprotective effects by clearing toxic RNA species (PubMed: 26300005). While no UPF1-targeted therapies are currently FDA-approved, small molecule inhibitors like NMDI-1 and antisense oligonucleotides are being utilized in preclinical research to evaluate the therapeutic potential of NMD modulation (PubChem CID: 2826652).
Inhibition of the nonsense-mediated mRNA decay (NMD) pathway by blocking UPF1 phosphorylation or its helicase activity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UPF1 RNA helicase and ATPase (UPF1).